About Columbia Labs

Columbia Laboratories (Nasdaq:CBRX) has a rich history in drug development. We offer broad formulation, development, manufacturing and analytical capabilities through our wholly-owned subsidiary, Molecular Profiles Ltd. Learn More

In the News

Molecular Profiles Ltd.

Founded in 1997 to provide high-end pharmaceutical analysis, Molecular Profiles is a world-class research provider successfully servicing both emerging and multi-national pharmaceutical companies and supporting the development of novel drugs.


Partners & Products

We commercialize our products through strategic alliances with partners including:


Our stringent criteria ensure our partners have the market knowledge and sales force capacity to sell our products in the specific markets they will address.

Current Events

09 Sept 2014 11:15am ET: CBRX presentation at Rodman & Renshaw 16th Annual Global Investment Conference - live and replay  

31 July 2014: CBRX Q2 2014 Conference Call - Archive 

CBRX Presentation

Download Columbia's investor presentation PDF